Pleiotropic Roles of a KEAP1-Associated Deubiquitinase, OTUD1
Daisuke Oikawa1, Kouhei Shimizu1, Fuminori Tokunaga1
1Department of Medical Biochemistry, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Antioxidants (Basel, Switzerland)
|February 25, 2023
Summary
OTUD1, a deubiquitinating enzyme (DUB), acts as a tumor suppressor by regulating cellular functions and immune responses. Its dysregulation is linked to cancer and autoimmune diseases, making OTUD1 a potential therapeutic target.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Biology
Background:
- Protein ubiquitination is a key post-translational modification regulating cellular processes.
- Deubiquitinating enzymes (DUBs) antagonistically control the ubiquitin system.
- OTUD1, an OTU family DUB, has diverse roles beyond its initial characterization.
Purpose of the Study:
- To elucidate the multifaceted roles of OTUD1 in cellular regulation.
- To investigate OTUD1's involvement in disease pathogenesis.
- To highlight OTUD1 as a potential therapeutic target.
Main Methods:
- Biochemical assays to determine OTUD1's enzymatic activity and substrate specificity.
- Analysis of OTUD1's involvement in various cellular pathways (e.g., immune response, oxidative stress).
- Correlation of OTUD1 dysregulation with disease states through literature review.
Main Results:
- OTUD1 targets multiple proteins including p53, PTEN, and AKT, predominantly acting as a tumor suppressor.
- OTUD1 regulates antiviral signaling, immune responses, and cell death pathways.
- OTUD1 is implicated in cancers, graft-versus-host disease, and autoimmune disorders.
Conclusions:
- OTUD1 is a crucial DUB with diverse regulatory functions.
- OTUD1's involvement in multiple diseases underscores its significance.
- Targeting OTUD1 presents a promising therapeutic strategy for various pathologies.
More Related Videos
09:45Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
9.7K
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
354
Related Concept Videos
01:13The Proteasome
928
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
928
01:32Export of Misfolded Proteins out of the ER
3.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K
01:37The Unfolded Protein Response
4.8K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.8K
02:58Regulated Protein Degradation
7.4K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.4K
01:31Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
02:04Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K